A carregar...
Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines
Acquired resistance to Herceptin is a major clinical problem in the treatment of HER2-overexpressing breast cancer. Understanding the molecular mechanisms leading to resistance will allow identification of novel therapeutic targets and predictors of therapeutic response. To this end, up-regulation o...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3233239/ https://ncbi.nlm.nih.gov/pubmed/22162984 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|